Skip to main content
Clinical Trials/EUCTR2004-002731-62-IT
EUCTR2004-002731-62-IT
Active, not recruiting
Not Applicable

OPTIMISATION OF INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS BY TELECARE ASSISTANCE FOR SELF MONITORING OF BLOOD GLUCOSE ELEONOR STUDY

AVENTIS PHARMA S.P.A.0 sites480 target enrollmentJanuary 3, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
TYPE 2 DIABETES MELLITUS
Sponsor
AVENTIS PHARMA S.P.A.
Enrollment
480
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 3, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AVENTIS PHARMA S.P.A.

Eligibility Criteria

Inclusion Criteria

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Study on insulin treatment for type 2 diabetes performed by general practitionersType 2 diabetes mellitus
JPRN-UMIN000011287General incorporated Tokyo Physicians Association.100
Not yet recruiting
Not Applicable
A Comparison of Peri-Operative and Post Acute Coronary Syndrome Glycaemic Control in Insulin Requiring Patients with Type 2 Diabetes at St Vincent’s Hospital With and Without Real-Time Continuous Glucose Monitoring.Type 2 diabetes requiring insulinAcute coronary syndromesPost - operative patientsMetabolic and Endocrine - DiabetesCardiovascular - Coronary heart diseaseSurgery - Surgical techniques
ACTRN12608000125325St Vincent's Hospital60
Completed
Phase 3
Improved treatment of type 2 diabetes mellitus by improving the splenic functions and gastro intestinal tract using naturally occurring bioactive compoundsSplenic and gastro intestinal disorder in Type 2 Diabetes Mellitusgastrointestinal disorderDiabetes mellitusMetabolic diseasesMetabolic and Endocrine - Diabetes
ACTRN12614000007639guyen Van Toan94
Completed
Not Applicable
Insulin combination therapy in type 2 diabetesDiabetes mellitus type 2 (DM type II)Nutritional, Metabolic, EndocrineDiabetes
ISRCTN29335793Stichting Julius Research (The Netherlands)200
Active, not recruiting
Not Applicable
Treatment Strategies in Patients with Type 2 Diabetes Mellitus Not Achieving Glycemic Control while on Therapy with Premixed Insulin Analogues and Metformin: A Comparison of Insulin Lispro MM Intensive Mixture Therapy with Progressive Dose-Titration of Insulin Lispro LM or Biphasic Insulin Aspart 30/70 - S019
EUCTR2006-003076-35-HUEli Lilly and Company Ltd.270